CN1551765A - 治疗男性睾酮缺乏的方法和材料 - Google Patents
治疗男性睾酮缺乏的方法和材料 Download PDFInfo
- Publication number
- CN1551765A CN1551765A CNA028174410A CN02817441A CN1551765A CN 1551765 A CN1551765 A CN 1551765A CN A028174410 A CNA028174410 A CN A028174410A CN 02817441 A CN02817441 A CN 02817441A CN 1551765 A CN1551765 A CN 1551765A
- Authority
- CN
- China
- Prior art keywords
- chloramiphene
- testosterone
- trans
- enclomifene
- zuclomiphene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
Abstract
Description
组别 | ID | 基线12/3/01 | 第0天12/7/01 | 第6天12/13/01 | 第12天12/20/01 | 洗脱12/26/01 |
氯米芬 | 750090129097 | 79.01 76.15 940.97 891.5 150.997.55 305.24 585.92 555.6 316.3158.06 102.94 151.12 318.9 143.6 | ||||
均值标准差 | 111.541.3 | 161.4125.2 | 559.3395.6 | 588.7287.7 | 203. 697.7 | |
恩氯米芬 | 722380218369 | 64.57 74.96 1223.8 633.6 307.2166.86 133.59 1128.2 1466 399.2170.45 106.47 1081.1 1166 271 | ||||
均值标准差 | 134.060.1 | 105.029.3 | 1144.472.7 | 1088.5421.6 | 325.866.1 | |
珠氯米芬 | 7438829210098 | 124.84 210.4 137.51 314.5 359.7104.66 67.37 169.98 406.1 860.5282.29 904.82 227.95 353.0 274.1 | ||||
均值标准差 | 170.697.3 | 394.2448.0 | 178.545.8 | 357.946.0 | 498.1316.8 |
Claims (4)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30431301P | 2001-07-09 | 2001-07-09 | |
US60/304,313 | 2001-07-09 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2006101356235A Division CN1954807A (zh) | 2001-07-09 | 2002-07-09 | 富含反式克罗米酚的克罗米酚组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1551765A true CN1551765A (zh) | 2004-12-01 |
CN1289075C CN1289075C (zh) | 2006-12-13 |
Family
ID=23175972
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2006101356235A Pending CN1954807A (zh) | 2001-07-09 | 2002-07-09 | 富含反式克罗米酚的克罗米酚组合物 |
CNB028174410A Expired - Lifetime CN1289075C (zh) | 2001-07-09 | 2002-07-09 | 富含反式克罗米酚的克罗米酚组合物的用途 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2006101356235A Pending CN1954807A (zh) | 2001-07-09 | 2002-07-09 | 富含反式克罗米酚的克罗米酚组合物 |
Country Status (24)
Country | Link |
---|---|
US (6) | US7759360B2 (zh) |
EP (1) | EP1411916B1 (zh) |
JP (2) | JP4845165B2 (zh) |
KR (1) | KR100851648B1 (zh) |
CN (2) | CN1954807A (zh) |
AT (1) | ATE406153T1 (zh) |
AU (1) | AU2002318225B2 (zh) |
BR (1) | BR0211067A (zh) |
CA (2) | CA2777199A1 (zh) |
CL (1) | CL2004000026A1 (zh) |
CO (1) | CO5550428A2 (zh) |
CY (1) | CY1108563T1 (zh) |
DE (1) | DE60228583D1 (zh) |
DK (1) | DK1411916T3 (zh) |
EC (1) | ECSP044937A (zh) |
ES (1) | ES2312593T3 (zh) |
HK (1) | HK1071521A1 (zh) |
MX (1) | MXPA04000097A (zh) |
NZ (2) | NZ530491A (zh) |
PL (1) | PL211339B1 (zh) |
PT (1) | PT1411916E (zh) |
RU (1) | RU2297218C2 (zh) |
WO (1) | WO2003005954A2 (zh) |
ZA (1) | ZA200400142B (zh) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1954807A (zh) | 2001-07-09 | 2007-05-02 | 佐纳根有限公司 | 富含反式克罗米酚的克罗米酚组合物 |
US7173064B2 (en) | 2001-07-09 | 2007-02-06 | Repros Therapeutics Inc. | Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy |
US7737185B2 (en) | 2001-07-09 | 2010-06-15 | Repros Therapeutics Inc. | Methods and compositions with trans-clomiphene |
WO2006019916A1 (en) * | 2004-07-14 | 2006-02-23 | Repros Therapeutics Inc. | Trans-clomiphene for the treatment of benign prostate hypertrophy, prostate cancer, hypogonadism, elevated triglycerides and high cholesterol |
BRPI0606528A8 (pt) | 2005-02-04 | 2018-03-13 | Repros Therapeutics Inc | composição para uso no fabrico de medicamentos de tratamento da infertilidade masculina e uso da mesma |
RU2413508C2 (ru) * | 2005-03-22 | 2011-03-10 | Репрос Терапьютикс Инк. | Режимы дозирования транс-кломифена |
US20080312239A1 (en) * | 2007-06-13 | 2008-12-18 | Quatrx Pharmaceuticals Company | Methods for the treatment of erectile dysfunction using fispemifene |
US20090105348A1 (en) * | 2007-10-18 | 2009-04-23 | Harry Fisch | Treatment of migraine headaches using antiestrogens |
US20110118355A1 (en) * | 2007-09-21 | 2011-05-19 | Harry Fisch | Treatment of migraine headaches using antiestrogens |
EP2826475B1 (en) * | 2007-10-16 | 2019-03-20 | Repros Therapeutics Inc. | Trans-clomiphene for treating diabetes in hypogonadal men |
US20090215733A1 (en) * | 2008-02-26 | 2009-08-27 | Michael Charles Scally | Therapy for the prophylaxis or treatment of adverse body composition changes and/or decreased muscle strength after androgen or gnrh analogue intake |
TWI477276B (zh) | 2008-04-28 | 2015-03-21 | Repros Therapeutics Inc | 抗黃體素給藥方案 |
RU2474424C2 (ru) * | 2010-09-24 | 2013-02-10 | Государственное образовательное учреждение высшего профессионального образования "Ивановская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" | Способ коррекции гиперэстрадиолемии и нормогонадотропного гипогонадизма у мужчин |
UA113291C2 (xx) | 2011-08-04 | 2017-01-10 | Метаболіти транскломіфену і їх застосування | |
WO2013020215A1 (en) * | 2011-08-09 | 2013-02-14 | Adams Kenneth W | Use of aromatase inhibitor or estrogen blocker for increasing spermatogenesis or testosterone levels in males |
SG11201407397WA (en) | 2012-05-31 | 2014-12-30 | Repros Therapeutics Inc | Formulations and methods for vaginal delivery of antiprogestins |
SG10201704820SA (en) * | 2012-08-21 | 2017-07-28 | Repros Therapeutics Inc | Trans-clomiphene formulations and uses thereof |
EP2914294A1 (en) | 2012-11-02 | 2015-09-09 | Repros Therapeutics Inc. | Trans-clomiphene for use in cancer therapy |
WO2014070517A1 (en) | 2012-11-02 | 2014-05-08 | Repros Therapeutics Inc. | Methods and compositions for treating progesterone-dependent conditions |
US9814687B2 (en) * | 2014-08-20 | 2017-11-14 | Professional Compounding Centers Of America | Transdermal pharmaceutical compositions including C-SERMs for low testosterone levels in men |
RU2586305C1 (ru) * | 2015-02-02 | 2016-06-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Ивановская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Способ лечения обструктивной азооспермии и криптозооспермии у пациентов с хроническим простатитом |
US10364212B2 (en) | 2016-04-22 | 2019-07-30 | F.I.S.—Fabbrica Italiana Sintetici S.p.A. | Process for the preparation of enclomiphene citrate having needle shaped crystal habit |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2914563A (en) | 1957-08-06 | 1959-11-24 | Wm S Merrell Co | Therapeutic composition |
IT951631B (it) | 1971-03-18 | 1973-07-10 | Richardson Merrell Spa | Composti utili per la separazione di isomeri ottici geometrici e strutturali e relativo procedimen to di sintesi |
US4061733A (en) * | 1976-10-15 | 1977-12-06 | Narayan Vishwanath Gunjikar | Veterinary compositions for inducing estrus in animals and method |
US4729999A (en) | 1984-10-12 | 1988-03-08 | Bcm Technologies | Antiestrogen therapy for symptoms of estrogen deficiency |
DE3660489D1 (en) | 1985-06-08 | 1988-09-15 | Asta Pharma Ag | Derivatives of 1,1,2,2-tetramethyl-1,2-bis(2-fluoro-4-hydroxyphenyl) ethane |
US4820736A (en) | 1987-03-20 | 1989-04-11 | Yale University | Use of clomiphene to predict fertility in a human female |
GB8926171D0 (en) | 1989-11-20 | 1990-01-10 | Applied Research Systems | Treatment of infertility |
JPH04312522A (ja) | 1991-04-08 | 1992-11-04 | Yoshiaki Kawashima | 徐放性錠剤の製造方法 |
US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5681585A (en) | 1991-12-24 | 1997-10-28 | Euro-Celtique, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
US5776923A (en) | 1993-01-19 | 1998-07-07 | Endorecherche, Inc. | Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone |
GB9405304D0 (en) | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
US5650425A (en) * | 1994-04-04 | 1997-07-22 | Pharmos Corporation | Permanently ionic derivatives of steroid hormones and their antagonists |
AU2638795A (en) | 1994-06-17 | 1996-01-15 | University Of Nebraska Board Of Regents | In situ gel-forming delivery vehicle for bio-affecting substances, and method of use |
DE4435368A1 (de) | 1994-09-22 | 1996-03-28 | Schering Ag | Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann |
EP0844870B1 (en) | 1995-08-17 | 2001-11-21 | Csir | Controlled release products |
US5773031A (en) | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
IL120262A (en) | 1996-02-28 | 2001-01-28 | Pfizer | Droloxifene and derivatives thereof for use in increasing serum testosterone levels |
ATE277739T1 (de) | 1996-10-28 | 2004-10-15 | Gen Mills Inc | Einbettung und einkapselung von teilchen zur kontrollierten abgabe |
IL132120A0 (en) | 1997-04-03 | 2001-03-19 | Guilford Pharm Inc | Biodegradable terephthalate polyester-poly (phosphate) polymers compositions articles and methods for making and using the same |
US6653297B1 (en) | 1997-07-03 | 2003-11-25 | Medical College Of Hampton Roads | Control of selective estrogen receptor modulators |
US6342250B1 (en) | 1997-09-25 | 2002-01-29 | Gel-Del Technologies, Inc. | Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices |
US6413533B1 (en) | 1998-05-07 | 2002-07-02 | The University Of Tennessee Research Corporation | Method for chemoprevention of prostate cancer |
US6291505B1 (en) | 1998-08-07 | 2001-09-18 | Chiron Corporation | Estrogen receptor modulators |
US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
PL352250A1 (en) | 1999-06-11 | 2003-08-11 | Watson Pharmaceuticals | Administration of non-oral androgenic steroids to women |
CA2321321A1 (en) | 1999-09-30 | 2001-03-30 | Isotis B.V. | Polymers loaded with bioactive agents |
US6258802B1 (en) | 1999-10-06 | 2001-07-10 | Medical College Of Hampton Roads | Corticoid therapy |
US20020004065A1 (en) | 2000-01-20 | 2002-01-10 | David Kanios | Compositions and methods to effect the release profile in the transdermal administration of active agents |
CA2409647C (en) * | 2000-05-26 | 2012-07-03 | Harry Fisch | Methods of treating androgen deficiency in men using selective antiestrogens |
US7067557B2 (en) | 2000-05-26 | 2006-06-27 | Harry Fisch | Methods of treating androgen deficiency in men using selective antiestrogens |
CA2416976C (en) | 2000-08-11 | 2008-05-20 | Wyeth | Treatment of estrogen receptor positive carcinoma with a rapamycin and an antiestrogen |
US6503894B1 (en) * | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
US20040192598A1 (en) | 2000-10-11 | 2004-09-30 | Laura Kragie | Composition and method of alleviating adverse side effects and/or enhancing efficacy of agents that inhibit aromatase |
US6743448B2 (en) | 2000-12-11 | 2004-06-01 | Abraham H. Kryger | Topical testosterone formulations and associated methods |
US7173064B2 (en) | 2001-07-09 | 2007-02-06 | Repros Therapeutics Inc. | Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy |
CN1954807A (zh) | 2001-07-09 | 2007-05-02 | 佐纳根有限公司 | 富含反式克罗米酚的克罗米酚组合物 |
US6645974B2 (en) | 2001-07-31 | 2003-11-11 | Merck & Co., Inc. | Androgen receptor modulators and methods for use thereof |
AU2002330031B2 (en) | 2001-09-21 | 2007-07-05 | Merck & Co., Inc. | Androstanes as androgen receptor modulators |
US6600110B1 (en) * | 2001-10-01 | 2003-07-29 | Gram Precision | Portable digital readout scale |
US20060269611A1 (en) | 2001-11-29 | 2006-11-30 | Steiner Mitchell S | Prevention and treatment of androgen-deprivation induced osteoporosis |
US7105679B2 (en) | 2001-12-19 | 2006-09-12 | Kanojia Ramesh M | Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
JP4312522B2 (ja) | 2003-06-30 | 2009-08-12 | 株式会社リコー | 現像剤補給方法、現像剤補給装置、及び、画像形成装置 |
WO2006019916A1 (en) | 2004-07-14 | 2006-02-23 | Repros Therapeutics Inc. | Trans-clomiphene for the treatment of benign prostate hypertrophy, prostate cancer, hypogonadism, elevated triglycerides and high cholesterol |
BRPI0606528A8 (pt) | 2005-02-04 | 2018-03-13 | Repros Therapeutics Inc | composição para uso no fabrico de medicamentos de tratamento da infertilidade masculina e uso da mesma |
AU2006213856B2 (en) | 2005-02-11 | 2011-03-17 | Regeneron Pharmaceuticals, Inc. | Therapeutic combination of a VEGF antagonist (VEGF trap) and an anti-hypertensive agent |
RU2413508C2 (ru) | 2005-03-22 | 2011-03-10 | Репрос Терапьютикс Инк. | Режимы дозирования транс-кломифена |
JP2009503096A (ja) | 2005-08-05 | 2009-01-29 | リプロス セラピューティクス インコーポレイテッド | クロミフェンを用いる女性不妊症を処置するための方法および組成物 |
EP1829534A1 (en) | 2006-03-02 | 2007-09-05 | Laboratorios Del Dr. Esteve, S.A. | Use of compounds binding to the sigma receptor for the treatment of metabolic syndrome |
EP2826475B1 (en) | 2007-10-16 | 2019-03-20 | Repros Therapeutics Inc. | Trans-clomiphene for treating diabetes in hypogonadal men |
US20100111901A1 (en) | 2008-11-03 | 2010-05-06 | Auspex Pharmaceuticals, Inc. | Triazole inhibitors of aromatase |
TWI458478B (zh) | 2008-11-07 | 2014-11-01 | Repros Therapeutics Inc | 用於代謝症候群與第2型糖尿病的反式氯米芬 |
US20100144687A1 (en) | 2008-12-05 | 2010-06-10 | Glaser Rebecca L | Pharmaceutical compositions containing testosterone and an aromatase inhibitor |
WO2013020215A1 (en) | 2011-08-09 | 2013-02-14 | Adams Kenneth W | Use of aromatase inhibitor or estrogen blocker for increasing spermatogenesis or testosterone levels in males |
-
2002
- 2002-07-09 CN CNA2006101356235A patent/CN1954807A/zh active Pending
- 2002-07-09 JP JP2003511763A patent/JP4845165B2/ja not_active Expired - Fee Related
- 2002-07-09 US US10/483,458 patent/US7759360B2/en not_active Expired - Fee Related
- 2002-07-09 CA CA2777199A patent/CA2777199A1/en not_active Abandoned
- 2002-07-09 PL PL374121A patent/PL211339B1/pl unknown
- 2002-07-09 MX MXPA04000097A patent/MXPA04000097A/es active IP Right Grant
- 2002-07-09 NZ NZ530491A patent/NZ530491A/en not_active IP Right Cessation
- 2002-07-09 CA CA2453337A patent/CA2453337C/en not_active Expired - Lifetime
- 2002-07-09 RU RU2004100535/14A patent/RU2297218C2/ru active
- 2002-07-09 KR KR1020047000258A patent/KR100851648B1/ko active IP Right Grant
- 2002-07-09 NZ NZ551013A patent/NZ551013A/en not_active IP Right Cessation
- 2002-07-09 AT AT02748104T patent/ATE406153T1/de active
- 2002-07-09 DK DK02748104T patent/DK1411916T3/da active
- 2002-07-09 EP EP02748104A patent/EP1411916B1/en not_active Expired - Lifetime
- 2002-07-09 BR BRPI0211067-9A patent/BR0211067A/pt not_active Application Discontinuation
- 2002-07-09 WO PCT/US2002/021524 patent/WO2003005954A2/en active Application Filing
- 2002-07-09 ES ES02748104T patent/ES2312593T3/es not_active Expired - Lifetime
- 2002-07-09 PT PT02748104T patent/PT1411916E/pt unknown
- 2002-07-09 AU AU2002318225A patent/AU2002318225B2/en not_active Expired
- 2002-07-09 CN CNB028174410A patent/CN1289075C/zh not_active Expired - Lifetime
- 2002-07-09 DE DE60228583T patent/DE60228583D1/de not_active Expired - Lifetime
-
2003
- 2003-04-30 US US10/427,768 patent/US7368480B2/en not_active Expired - Lifetime
-
2004
- 2004-01-06 EC EC2004004937A patent/ECSP044937A/es unknown
- 2004-01-08 CL CL200400026A patent/CL2004000026A1/es unknown
- 2004-01-08 ZA ZA200400142A patent/ZA200400142B/en unknown
- 2004-01-09 CO CO04001222A patent/CO5550428A2/es not_active Application Discontinuation
-
2005
- 2005-05-25 HK HK05104390A patent/HK1071521A1/xx not_active IP Right Cessation
-
2008
- 2008-11-13 CY CY20081101298T patent/CY1108563T1/el unknown
-
2009
- 2009-09-03 JP JP2009204154A patent/JP2009280623A/ja not_active Withdrawn
-
2010
- 2010-07-16 US US12/838,036 patent/US8618176B2/en not_active Expired - Lifetime
-
2013
- 2013-12-03 US US14/095,494 patent/US20140093560A1/en not_active Abandoned
-
2015
- 2015-06-09 US US14/734,931 patent/US20150265553A1/en not_active Abandoned
-
2016
- 2016-08-17 US US15/239,394 patent/US10561624B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1289075C (zh) | 富含反式克罗米酚的克罗米酚组合物的用途 | |
CN101163467B (zh) | 反式氯米芬的制药用途 | |
RU2404757C2 (ru) | Способы и материалы с транс-кломифеном для лечения мужского бесплодия | |
US20080242726A1 (en) | Trans-Clomiphene for the Treatment of Benign Prostate Hypertrophy, Porstate Cancer, Hypogonadism Elevated Triglycerides and High Cholesterol | |
AU2002318225A1 (en) | Methods and materials for the treatment of testosterone deficiency in men | |
US7173064B2 (en) | Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy | |
AU2008201142B2 (en) | Methods and materials for the treatment of testosterone deficiency in men |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1071521 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1071521 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: LIPKIN BIO-PHARMACEUTICAL COMPANY Free format text: FORMER OWNER: ZONAGEN CO., LTD. Effective date: 20071123 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20071123 Address after: Texas, USA Patentee after: REPROS THERAPEUTICS Inc. Address before: Texas, USA Patentee before: Zonagen, Inc. |
|
CX01 | Expiry of patent term |
Granted publication date: 20061213 |
|
CX01 | Expiry of patent term |